Skip to search formSkip to main contentSkip to account menu

ABT 279

Known as: ABT-279, ABT279 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Retrospective and Prospective Human Intravenous and Oral Pharmacokinetic Projection of Dipeptidyl peptidase-IV Inhibitors Using Simple Allometric Principles - Case Studies of ABT-279, ABT-341…
PURPOSE The purpose of this exercise was to explore the utility of allometric scaling approach for the prediction of intravenous… 
2006
2006
Developing multiple high-throughput GLP methods for an investigational drug candidate in various matrices within a 96-well plate.
In early pharmaceutical product development, an investigational drug candidate is typically dosed to various species for… 
2006
2006
ABT‐279 is a potent and selective inhibitor of DPPIV
ABT‐279 is a potent and selective inhibitor of dipeptidylpeptidase IV (DPPIV, EC 3.4.14.5). We report here it is a competitive… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)